Cargando…

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications

Diabetes mellitus is a metabolic disease that is characterized by chronic hyperglycemia due to a variety of etiological factors. Long-term metabolic stress induces harmful inflammation leading to chronic complications, mainly diabetic ophthalmopathy, diabetic cardiovascular complications and diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Dan, Zhang, Zhen, Liu, Jieting, Chen, Peijian, Dai, Yucen, Sun, Xinhai, Chu, Yanhui, Li, Luxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639174/ https://www.ncbi.nlm.nih.gov/pubmed/37954576 http://dx.doi.org/10.3389/fimmu.2023.1274654

Ejemplares similares

RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)

Targeting RIPK1 kinase for modulating inflammation in human diseases
por: Li, Wanjin, et al.
Publicado: (2023)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy
por: Ke, Dan, et al.
Publicado: (2023)

RIPK1-Associated Inborn Errors of Innate Immunity
por: Zhang, Jiahui, et al.
Publicado: (2021)

Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
por: Garcia-Carbonell, Ricard, et al.
Publicado: (2019)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation
por: Duan, Xiaoru, et al.
Publicado: (2020)

Comprehensive Evolutionary Analysis of Lamprey TNFR-Associated Factors (TRAFs) and Receptor-Interacting Protein Kinase (RIPKs) and Insights Into the Functional Characterization of TRAF3/6 and RIPK1
por: Hou, Jianqiang, et al.
Publicado: (2020)

RIPK1 blocks T cell senescence mediated by RIPK3 and caspase-8
por: Imanishi, Takayuki, et al.
Publicado: (2023)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
por: Moujalled, D M, et al.
Publicado: (2013)

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015)

Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation
por: Seong, Daehyeon, et al.
Publicado: (2020)

Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015)

RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
por: Sultan, Mutaz, et al.
Publicado: (2022)

RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
por: Liu, Xiaoyu, et al.
Publicado: (2023)

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023)

Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014)

TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
por: Dowling, John P., et al.
Publicado: (2019)

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
por: Frank, Daniel, et al.
Publicado: (2022)

KW2449 ameliorates collagen-induced arthritis by inhibiting RIPK1-dependent necroptosis
por: Wang, Qiong, et al.
Publicado: (2023)

O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
por: Seo, Junghwa, et al.
Publicado: (2023)

Corrigendum: RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Primidone blocks RIPK1-driven cell death and inflammation
por: Riebeling, Theresa, et al.
Publicado: (2020)

Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3(+) and CD8(+) T cell density and predict prognosis in hepatocellular carcinoma
por: Nicolè, Lorenzo, et al.
Publicado: (2022)

RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system
por: Li, Dianrong, et al.
Publicado: (2017)

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
por: Newton, K, et al.
Publicado: (2016)

Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
por: Li, Luxin, et al.
Publicado: (2023)

Execution of RIPK3-regulated necrosis
por: Cai, Zhenyu, et al.
Publicado: (2014)

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
por: Moriwaki, K, et al.
Publicado: (2015)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Zhang, Xixi, et al.
Publicado: (2019)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose
por: Gao, Sheng, et al.
Publicado: (2021)

RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
por: Contreras, Christopher J., et al.
Publicado: (2022)

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1
por: Peng, Ruoshi, et al.
Publicado: (2022)

Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
por: Takiishi, Tatiana, et al.
Publicado: (2023)

Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells
por: Blanchett, Sam, et al.
Publicado: (2022)

Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis
por: Liu, Shuo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4uuejik9vloautnnkgel3qrio7